All posts by medical

Human Behavior

No second wave of Covid-19 in the US. The first never really ended – ThePrint

Text Size:A- A+

After sustained declines in the number of COVID-19 cases over recent months, restrictions are starting to ease across the United States. Numbers of new cases are falling or stable at low numbers in some states, but they are surging in many others. Overall, the U.S. is experiencing a sharp increase in the number of new cases a day, and by late June, had surpassed the peak rate of spread in early April.

When seeing these increasing case numbers, it is reasonable to wonder if this is the dreaded second wave of the coronavirus a resurgence of rising infections after a reduction in cases.

The U.S. as a whole is not in a second wave because the first wave never really stopped. The virus is simply spreading into new populations or resurging in places that let down their guard too soon.

A wave of an infection describes a large rise and fall in the number of cases. There isnt a precise epidemiological definition of when a wave begins or ends.

But with talk of a second wave in the news, as an epidemiologist and public health researcher, I think there are two necessary factors that must be met before we can colloquially declare a second wave.

First, the virus would have to be controlled and transmission brought down to a very low level. That would be the end of the first wave. Then, the virus would need to reappear and result in a large increase in cases and hospitalizations.

Many countries in Europe and Asia have successfully ended the first wave. New Zealand and Iceland have also made it through their first waves and are now essentially coronavirus-free, with very low levels of community transmission and only a handful of active cases currently.

In the U.S., cases spiked in March and April and then trended downward due to social distancing guidance and implementation. However, the U.S. never reduced spread to low numbers that were sustained over time. Through May and early June, numbers plateaued at approximately 25,000 new cases daily.

We have left that plateau. Since mid-June, cases have been surging upwards. Additionally, the percentage of COVID-19 tests that are returning positive is climbing steeply, indicating that the increase in new cases is not simply a result of more testing, but the result of an increase in spread.

As of writing this, new deaths per day have not begun to climb, but some hospitals intensive care units have recently reached full capacity. In the beginning of the outbreak, deaths often lagged behind confirmed infections. It is likely, as Anthony Fauci, the nations top infectious-disease specialist said on June 22, that deaths will soon follow the surge in new cases.

Also read: US FDA wants a coronavirus vaccine that really works

Looking at U.S. numbers as a whole hides what is really going on. Different states are in vastly different situations right now and when you look at states individually, four major categories emerge.

The trends arent surprising based on how states have been dealing with reopening. The virus will go wherever there are susceptible people and until the U.S. stops community spread across the entire country, the first wave isnt over.

It is possible though at this point it seems unlikely that the U.S. could control the virus before a vaccine is developed. If that happens, it would be time to start thinking about a second wave. The question of what it might look like depends in large part on everyones actions.

The 1918 flu pandemic was characterized by a mild first wave in the winter of 1917-1918 that went away in summer. After restrictions were lifted, people very quickly went back to pre-pandemic life. But a second, deadlier strain came back in fall of 1918 and third in spring of 1919. In total, more than 500 million people were infected worldwide and upwards of 50 million died over the course of three waves.

It was the combination of a quick return to normal life and a mutation in the flus genome that made it more deadly that led to the horrific second and third waves.

Thankfully, the coronavirus appears to be much more genetically stable than the influenza virus, and thus less likely to mutate into a more deadly variant. That leaves human behavior as the main risk factor.

Until a vaccine or effective treatment is developed, the tried-and-true public health measures of the last months social distancing, universal mask wearing, frequent hand-washing and avoiding crowded indoor spaces are the ways to stop the first wave and thwart a second one. And when there are surges like what is happening now in the U.S., further reopening plans need to be put on hold.

Melissa Hawkins, Professor of Public Health, Director of Public Health Scholars Program, American University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Also read: Trumps reelection campaign is in crisis

ThePrint is now on Telegram. For the best reports & opinion on politics, governance and more, subscribe to ThePrint on Telegram.

Subscribe to our YouTube channel.

Original post:
No second wave of Covid-19 in the US. The first never really ended - ThePrint

Human Behavior

It’s summer, it’s hot and sunny, and COVID-19 didn’t go away. Why not? – yoursun.com

The coronavirus is still here despite the warmer weather.

As summer plans adjust to a growing pandemic, its important to understand why people still need to take caution against COVID-19.

Many infectious diseases are seasonal, so its not unreasonable to wonder if COVID-19 could be as well. Flu famously begins to increase in the fall and spike in the winter. When polio was still a widespread disease, the worst outbreaks were in the summer. But understanding why a disease is seasonal can be hard work.

Popular culture started to associate polio outbreaks with summer swimming after Franklin Roosevelt caught the disease on vacation, but chlorine would kill the virus in the water. Widespread vaccination banished polio from most of the world before the cause of polio season was understood.

The cause for the flu season is still not fully understood. Some doctors attribute it to human behavior, as people spend more time closer together indoors in colder weather. Other theories suggest the weather causes important physical changes.

For instance, studies show flu viruses are more easily spread in colder, drier air. But theres some doubt over whether this is because of a trait of the flu virus or because the lungs may be more vulnerable to infection in those conditions. And in tropical environments, flu is actually a year-round disease, and may spread more easily in moist air.

Some early studies on the coronavirus responsible for COVID-19 saw that, like the flu virus, it does have a harder time surviving in hotter, wetter environments. But this doesnt make it much safer to gather closely with other people, according to Timothy Sheahan, a virologist at the University of North Carolina at Chapel Hill.

New studies show breathing in the coronavirus is the main way it spreads, and touching contaminated objects is less likely to infect someone. If two people are close together, breathing in the same air, it doesnt give a hot day much time to kill the virus.

This is also the problem with sunlight. While its thought that ultraviolet, or UV, light can kill the virus, a sunny day wont stop COVID-19. The most energetic kind of UV light that could kill the virus in a short amount of time is also the UV light most blocked out by the atmosphere.

While hospitals and labs use specialized UV light sources to sterilize equipment, theyre very powerful compared to daylight. If you shined that light on your skin, youd get torched, Sheahan said.

Humans having no previous exposure, and therefore no immunity, to the coronavirus is likely to be more important for how the pandemic plays out in the next few months. This is also why the H1N1 flu pandemic in 2009 broke out in summer, because the strain was one most people had never been exposed to before.

The COVID-19 virus closest-known relative caused SARS, which didnt get a chance to become seasonal because traditional public health measures easily contained it. With the original SARS coronavirus, you were contagious on the onset of symptoms, Sheahan said.

Two different coronaviruses that cause colds are seasonal. According to Sheahan, this is because they dont provide lifelong immunity. The cold-causing coronaviruses are globally spread, so people routinely get reinfected after their immunity fades away over time.

Depending on how the pandemic plays out, theres a chance COVID-19 could end up becoming a seasonal disease. This may depend on how long immunity against the disease lasts.

Say someone designs a vaccine that gives you lifelong immunity. Great! But that might not be possible, Sheahan said. This may be because immunity fades away. And coronaviruses easily mutate, so its possible COVID-19 could mutate to dodge the original immunity a vaccine provides, similar to how seasonal flu changes.

The more widespread and established COVID-19 becomes, the harder it will be to eliminate. Sheahan is especially concerned about stories of humans spreading COVID-19 to other animals. If the coronavirus becomes established in other species, they could act as a reservoir that reinfects people even after the current pandemic of human-to-human transmission ends.

If COVID-19 cant be eliminated and becomes a seasonal disease, its hard to predict what it may look like. The seasonal cold-causing coronaviruses started to infect humans in the 1800s. Sheahan is curious to know what the diseases they caused looked like back then.

Was it a more severe respiratory disease, like COVID-19, or was it just a common cold? he asked. Do these things tell us about our future by looking at our past?

See the original post here:
It's summer, it's hot and sunny, and COVID-19 didn't go away. Why not? - yoursun.com

Human Behavior

Workplace Transformation Market Is Predicted To Exceed $41.5 Billion By 2027 | Grand View Research, Inc – Virtual-Strategy Magazine

Grand View Research, Inc. Market Research And Consulting.

According to report published by Grand View Research, the global workplace transformation market size was valued at USD 11.9 billion in 2019 and is expected to gain traction over the forecast period.

The globalworkplace transformation marketsize is expected to reach USD 41.5 billion by 2027, registering a CAGR of 17.0% from 2020 to 2027, according to a new report by Grand View Research, Inc. The workplace transformation provides agility and flexibility to workers, improving their overall performance and productivity. Several organizations across the globe are acknowledging the need for transforming their workplace, which in turn is expected to boost the market. Further, the adoption of supporting technologies such as endpoint security and remote accessibility is allowing employees to cooperate more effectively, regardless of their location, is a major factor enabling market growth.

Workplace transformation is the mixture of real estate, human behavior, and latest technology resulting in overall cost optimization with the flexibility of cooperative environment facilitating innovation and efficiency. In the contemporary competitive and modern-day workstation, the workplace transformation ensures that applications are transferred from a centralized location to an isolated environment on the targeted device. By enabling a connected enterprise, the organizations ensure free environment, in which, shared data and knowledge is always accessible. This, in turn, is helping to increase business velocity and agility and is further propelling market growth.

The advancement in mobile technologies and changing workforce demographics is driving the market. Workforce satisfaction is increasingly becoming the focus area of organizational strategies. Companies across industries are adopting comprehensive workplace transformation services that enable virtualization, collaboration, mobility, employee productivity, and employee satisfaction. With these services, organizations are providing immediate access to business-critical data and enterprise applications on various devices, such as tablets, smartphones, and laptops, while preserving security constraints. Thus, with the growing technological advancements, the workplace transformation market is expected to experience significant growth.

In early 2020, due to the widespread outbreak of Coronavirus disease (COVID-19), governments across the globe initiated steps such as self-quarantine and social distancing, due to which, organizations accentuated their focus on framing and adopting work from home policies to combat the spread of the pandemic. This necessitated organizations to provide secure and stable access to enterprise architecture and collaboration tools, subsequently driving market growth. Even beyond a pandemic, it is imperative that businesses should be supported by the latest technologies to streamline the processes and mitigate such risks proactively. Hence, enabling workplace transformation services becomes essential for ensuring business continuity.

Browse Details of Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/workplace-transformation-market

Key Takeaways from the report:

Request For Free Sample Report @ https://www.grandviewresearch.com/industry-analysis/workplace-transformation-market/request/rs1

Grand View Research has segmented the global workplace transformation market based on service, enterprise size, end use, and region:

Workplace Transformation Service Outlook (Revenue, USD Million, 2016 2027)

Workplace Transformation Enterprise Size Outlook (Revenue, USD Million, 2016 2027)

Workplace Transformation End-use Outlook (Revenue, USD Million, 2016 2027)

Workplace Transformation Regional Outlook (Revenue, USD Million, 2016 2027)

List of Key Players in Workplace Transformation Market

Browse Related Reports :

Conversational Systems Market Size, Share & Trends Analysis Report By Component, By Type (Text Assistant, Voice Assisted), By Application, By End Use, By Region, And Segment Forecasts, 2020 2027

https://www.grandviewresearch.com/industry-analysis/workplace-transformation-market

Sales Force Automation Software Market Size, Share & Trends Analysis Report By Deployment, By Enterprise Size, By Application (Lead Management, Sales Forecasting), By End Use, By Region, And Segment Forecasts, 2020 2027

https://www.grandviewresearch.com/industry-analysis/workplace-transformation-market/request/rs1

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address: 201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/workplace-transformation-market

Read more:
Workplace Transformation Market Is Predicted To Exceed $41.5 Billion By 2027 | Grand View Research, Inc - Virtual-Strategy Magazine

Human Behavior

The US isn’t in a second wave of coronavirus the first wave never ended – The Conversation US

After sustained declines in the number of COVID-19 cases over recent months, restrictions are starting to ease across the United States. Numbers of new cases are falling or stable at low numbers in some states, but they are surging in many others. Overall, the U.S. is experiencing a sharp increase in the number of new cases a day, and by late June, had surpassed the peak rate of spread in early April.

When seeing these increasing case numbers, it is reasonable to wonder if this is the dreaded second wave of the coronavirus a resurgence of rising infections after a reduction in cases.

The U.S. as a whole is not in a second wave because the first wave never really stopped. The virus is simply spreading into new populations or resurging in places that let down their guard too soon.

A wave of an infection describes a large rise and fall in the number of cases. There isnt a precise epidemiological definition of when a wave begins or ends.

But with talk of a second wave in the news, as an epidemiologist and public health researcher, I think there are two necessary factors that must be met before we can colloquially declare a second wave.

First, the virus would have to be controlled and transmission brought down to a very low level. That would be the end of the first wave. Then, the virus would need to reappear and result in a large increase in cases and hospitalizations.

Many countries in Europe and Asia have successfully ended the first wave. New Zealand and Iceland have also made it through their first waves and are now essentially coronavirus-free, with very low levels of community transmission and only a handful of active cases currently.

[Get our best science, health and technology stories. Sign up for The Conversations science newsletter.]

In the U.S., cases spiked in March and April and then trended downward due to social distancing guidance and implementation. However, the U.S. never reduced spread to low numbers that were sustained over time. Through May and early June, numbers plateaued at approximately 25,000 new cases daily.

We have left that plateau. Since mid-June, cases have been surging upwards. Additionally, the percentage of COVID-19 tests that are returning positive is climbing steeply, indicating that the increase in new cases is not simply a result of more testing, but the result of an increase in spread.

As of writing this, new deaths per day have not begun to climb, but some hospitals intensive care units have recently reached full capacity. In the beginning of the outbreak, deaths often lagged behind confirmed infections. It is likely, as Anthony Fauci, the nations top infectious-disease specialist said on June 22, that deaths will soon follow the surge in new cases.

Looking at U.S. numbers as a whole hides what is really going on. Different states are in vastly different situations right now and when you look at states individually, four major categories emerge.

Places where the first wave is ending: States in the Northeast and a few scattered elsewhere experienced large initial spikes but were able to mostly contain the virus and substantially brought down new infections. New York is a good example of this.

Places still in the first wave: Several states in the South and West see Texas and California had some cases early on, but are now seeing massive surges with no sign of slowing down.

Places in between: Many states were hit early in the first wave, managed to slow it down, but are either at a plateau like North Dakota or are now seeing steep increases like Oklahoma.

Places experiencing local second waves: Looking only at a state level, Hawaii, Montana and Alaska could be said to be experiencing second waves. Each state experienced relatively small initial outbreaks and was able to reduce spread to single digits of daily new confirmed cases, but are now all seeing spikes again.

The trends arent surprising based on how states have been dealing with reopening. The virus will go wherever there are susceptible people and until the U.S. stops community spread across the entire country, the first wave isnt over.

It is possible though at this point it seems unlikely that the U.S. could control the virus before a vaccine is developed. If that happens, it would be time to start thinking about a second wave. The question of what it might look like depends in large part on everyones actions.

The 1918 flu pandemic was characterized by a mild first wave in the winter of 1917-1918 that went away in summer. After restrictions were lifted, people very quickly went back to pre-pandemic life. But a second, deadlier strain came back in fall of 1918 and third in spring of 1919. In total, more than 500 million people were infected worldwide and upwards of 50 million died over the course of three waves.

It was the combination of a quick return to normal life and a mutation in the flus genome that made it more deadly that led to the horrific second and third waves.

Thankfully, the coronavirus appears to be much more genetically stable than the influenza virus, and thus less likely to mutate into a more deadly variant. That leaves human behavior as the main risk factor.

Until a vaccine or effective treatment is developed, the tried-and-true public health measures of the last months social distancing, universal mask wearing, frequent hand-washing and avoiding crowded indoor spaces are the ways to stop the first wave and thwart a second one. And when there are surges like what is happening now in the U.S., further reopening plans need to be put on hold.

Read more from the original source:
The US isn't in a second wave of coronavirus the first wave never ended - The Conversation US

Neuroscience

Neuroscience Antibodies and Assays Market Trends 2020-2024 with Opportunities, Challenges and Companies’ Profile | Thermo Fisher, Abcam, Bio-Rad – 3rd…

Competitive Market Research Report on Global Neuroscience Antibodies and Assays Market with focus on Industry Analysis, Growth Opportunities, Risk Analysis, Current Trends, Competitive Landscape, Investment Strategies and Forecast by 2024.

The report contains in-depth information on all the key aspects of the global Neuroscience Antibodies and Assays market. This report contains important data such as facts & figures, market research, market analysis, SWOT analysis, competitive landscape, regional analysis and future growth prospects. The report also contains qualitative and quantitative research which gives you a detailed analysis of the global Neuroscience Antibodies and Assays market. The report is perfect as you can see information on the recent developments, based on which you can make risk assessments and investments in the Neuroscience Antibodies and Assays industry.

Get The Sample Report PDF with Detail TOC & List of [emailprotected]https://marketresearchport.com/request-sample/5148

Leading Companies Covered:

Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Roche, Siemens

This global Neuroscience Antibodies and Assays market research report has data of all the leading players operating in the industry. From their market shares in the industry, to their growth plans, recent development status, all important information has been compiled in the report to let you get an insightful look at the top players operating in the industry. The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.

Market Research is Further Divided into Following Segments:

Market Segmentation by Product Types:Consumables, Instruments

Market Segmentation by Applications:Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers

Regions Mentioned in the Global Neuroscience Antibodies and Assays Market:

The Middle East and Africa North America South America Europe Asia-Pacific Middle East Oceania Rest of the World

The data of the market research report has been studied, compiled and corroborated by leading industry experts and established authors. The format followed in the report is in accordance with most international market research reports. However, if you have any specific requirements, just get in touch with us, and we will customize the report accordingly as per your needs.

Do Enquiry For Customized Report as per Your [emailprotected]https://marketresearchport.com/enquiry-before-buying/5148

Table of Content:1 Industry Overview of Neuroscience Antibodies and Assays1.1 Brief Introduction of Neuroscience Antibodies and Assays1.1.1 Definition of Neuroscience Antibodies and Assays1.1.2 Development of Neuroscience Antibodies and Assays Industry1.2 Classification of Neuroscience Antibodies and Assays1.3 Status of Neuroscience Antibodies and Assays Industry1.3.1 Industry Overview of Neuroscience Antibodies and Assays1.3.2 Global Major Regions Status of Neuroscience Antibodies and Assays

2 Industry Chain Analysis of Neuroscience Antibodies and Assays2.1 Supply Chain Relationship Analysis of Neuroscience Antibodies and Assays2.2 Upstream Major Raw Materials and Price Analysis of Neuroscience Antibodies and Assays2.3 Downstream Applications of Neuroscience Antibodies and Assays

3 Manufacturing Technology of Neuroscience Antibodies and Assays3.1 Development of Neuroscience Antibodies and Assays Manufacturing Technology3.2 Manufacturing Process Analysis of Neuroscience Antibodies and Assays3.3 Trends of Neuroscience Antibodies and Assays Manufacturing Technology

4 Major Manufacturers Analysis of Neuroscience Antibodies and Assays4.1 Company 14.1.1 Company Profile4.1.2 Product Picture and Specifications4.1.3 Capacity, Production, Price, Cost, Gross and Revenue4.1.4 Contact Information4.2 Company 24.2.1 Company Profile4.2.2 Product Picture and Specifications4.2.3 Capacity, Production, Price, Cost, Gross and Revenue4.2.4 Contact Information4.3 Company 34.3.1 Company Profile4.3.2 Product Picture and Specifications4.3.3 Capacity, Production, Price, Cost, Gross and Revenue4.3.4 Contact Information4.4 Company 44.4.1 Company Profile4.4.2 Product Picture and Specifications4.4.3 Capacity, Production, Price, Cost, Gross and Revenue4.4.4 Contact Information4.5 Company 54.5.1 Company Profile4.5.2 Product Picture and Specifications4.5.3 Capacity, Production, Price, Cost, Gross and Revenue4.5.4 Contact Information4.6 Company 64.6.1 Company Profile4.6.2 Product Picture and Specifications4.6.3 Capacity, Production, Price, Cost, Gross and Revenue4.6.4 Contact Information4.7 Company 74.7.1 Company Profile4.7.2 Product Picture and Specifications4.7.3 Capacity, Production, Price, Cost, Gross and Revenue4.7.4 Contact Information4.8 Company 84.8.1 Company Profile4.8.2 Product Picture and Specifications4.8.3 Capacity, Production, Price, Cost, Gross and Revenue4.8.4 Contact Information4.9 Company 94.9.1 Company Profile4.9.2 Product Picture and Specifications4.9.3 Capacity, Production, Price, Cost, Gross and Revenue4.9.4 Contact Information4.10 Company ten4.10.1 Company Profile4.10.2 Product Picture and Specifications4.10.3 Capacity, Production, Price, Cost, Gross and Revenue4.10.4 Contact Information

5 Global Productions, Revenue and Price Analysis of Neuroscience Antibodies and Assays by Regions, Manufacturers, Types and Applications5.1 Global Production, Revenue of Neuroscience Antibodies and Assays by Regions 2014-20195.2 Global Production, Revenue of Neuroscience Antibodies and Assays by Manufacturers 2014-20195.3 Global Production, Revenue of Neuroscience Antibodies and Assays by Types 2014-20195.4 Global Production, Revenue of Neuroscience Antibodies and Assays by Applications 2014-20195.5 Price Analysis of Global Neuroscience Antibodies and Assays by Regions, Manufacturers, Types and Applications in 2014-2019

6 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuroscience Antibodies and Assays 2014-20196.1 Global Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.2 Asia Pacific Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.3 Europe Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.4 Middle East & Africa Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.5 North America Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-20196.6 Latin America Capacity, Production, Price, Cost, Revenue, of Neuroscience Antibodies and Assays 2014-2019

7 Consumption Volumes, Consumption Value, Import, Export and Sale Price Analysis of Neuroscience Antibodies and Assays by Regions7.1 Global Consumption Volume and Consumption Value of Neuroscience Antibodies and Assays by Regions 2014-20197.2 Global Consumption Volume, Consumption Value and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.3 Asia Pacific Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.4 Europe Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.5 Middle East & Africa Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.6 North America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.7 Latin America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Neuroscience Antibodies and Assays 2014-20197.8 Sale Price Analysis of Global Neuroscience Antibodies and Assays by Regions 2014-2019

8 Gross and Gross Margin Analysis of Neuroscience Antibodies and Assays8.1 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Regions 2014-20198.2 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Manufacturers 2014-20198.3 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Types 2014-20198.4 Global Gross and Gross Margin of Neuroscience Antibodies and Assays by Applications 2014-2019

9 Marketing Traders or Distributor Analysis of Neuroscience Antibodies and Assays9.1 Marketing Channels Status of Neuroscience Antibodies and Assays9.2 Marketing Channels Characteristic of Neuroscience Antibodies and Assays9.3 Marketing Channels Development Trend of Neuroscience Antibodies and Assays

10 Global and Chinese Economic Impacts on Neuroscience Antibodies and Assays Industry10.1 Global and Chinese Macroeconomic Environment Analysis10.1.1 Global Macroeconomic Analysis and Outlook10.1.2 Chinese Macroeconomic Analysis and Outlook10.2 Effects to Neuroscience Antibodies and Assays Industry

11 Development Trend Analysis of Neuroscience Antibodies and Assays11.1 Capacity, Production and Revenue Forecast of Neuroscience Antibodies and Assays by Regions, Types and Applications11.1.1 Global Capacity, Production and Revenue of Neuroscience Antibodies and Assays by Regions 2019-202411.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuroscience Antibodies and Assays 2019-202411.1.3 Global Capacity, Production and Revenue of Neuroscience Antibodies and Assays by Types 2019-202411.2 Consumption Volume and Consumption Value Forecast of Neuroscience Antibodies and Assays by Regions11.2.1 Global Consumption Volume and Consumption Value of Neuroscience Antibodies and Assays by Regions 2019-202411.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Neuroscience Antibodies and Assays 2019-202411.3 Supply, Import, Export and Consumption Forecast of Neuroscience Antibodies and Assays11.3.1 Supply, Consumption and Gap of Neuroscience Antibodies and Assays 2019-202411.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.5 Asia Pacific Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.6 Middle East & Africa Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-202411.3.7 Latin America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuroscience Antibodies and Assays 2019-2024

12 Contact information of Neuroscience Antibodies and Assays12.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Neuroscience Antibodies and Assays12.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Neuroscience Antibodies and Assays12.1.2 Major Equipment Suppliers with Contact Information Analysis of Neuroscience Antibodies and Assays12.2 Downstream Major Consumers Analysis of Neuroscience Antibodies and Assays12.3 Major Suppliers of Neuroscience Antibodies and Assays with Contact Information12.4 Supply Chain Relationship Analysis of Neuroscience Antibodies and Assays

13 New Project Investment Feasibility Analysis of Neuroscience Antibodies and Assays13.1 New Project SWOT Analysis of Neuroscience Antibodies and Assays13.2 New Project Investment Feasibility Analysis of Neuroscience Antibodies and Assays13.2.1 Project Name13.2.2 Investment Budget13.2.3 Project Product Solutions13.2.4 Project Schedule

14 Conclusion of the Global Neuroscience Antibodies and Assays Industry 2019 Market Research Report

About Us:Market Research Port is one of the best report resellers in the market bringing to you accurate and trustworthy market research reports by reputed publishers. Our trusted publishers have compiled their reports and findings after painstaking research and studies, set up against varied business parameters. Each report is detailed and then vetted for accuracy by industry experts. In each report, you will find deep analysis, risk analysis, market forecasts, emerging trends, different market segments, technological advancement and its impact, and a multitude of economic factors, giving you the most comprehensive market research report. You get many advantages with such comprehensive reports.

Contact Us:Market Research Port,Brighton Street, Providence,Rhode Island 02929, United StatesContact No: +1 401 433 7610Email: [emailprotected]Website: https://marketresearchport.com/

See more here:
Neuroscience Antibodies and Assays Market Trends 2020-2024 with Opportunities, Challenges and Companies' Profile | Thermo Fisher, Abcam, Bio-Rad - 3rd...

Neuroscience

Global Neuroscience Antibodies and Assays Market 2020 With COVID-19 Impact on Company, Regions, Type and Application, Forecast to 2025 – NJ MMA News

Global Neuroscience Antibodies and Assays Market 2020 by Company, Regions, Type and Application, Forecast to 2025carefully researches each trend and the major factors accountable for driving the growth of the Industry. The report largely concentrates on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. The report initially discusses the market definition, market overview, product description, product scope, product characterization, and product specification details. The market dynamics section explores the drivers, restraints, trends, and opportunities of the globalNeuroscience Antibodies and Assaysmarket.

NOTE:Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overallNeuroscience Antibodies and Assaysindustry.

Get Free Sample Report:https://www.researchstore.biz/sample-request/15046

The factors affecting the leading industry players to adopt sourcing of the market products have also been studied in this comprehensive report. Every organization taking part in the global production of the globalNeuroscience Antibodies and Assaysmarket products have been included in this report. The report aims to study the insights on cost-effective manufacturing methods, competitive landscape, and new avenues for applications. The market report accommodates market drivers and challenges & opportunities for a national level market in the particular provincial sections. It also provides the current industry value according to demand.

Scope of The Report:

The report evaluates investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume, and end-use. All key factors that help business owners identify the next leg for growth are presented through useful resources such as charts, tables, and graphic images. The analysts believe that in the next few years, globalNeuroscience Antibodies and Assaysmarket size will be further expanded, we expect that by 2025, the market will achieve the highest growth.

Following top key players are profiled with global positioning:Thermo Fisher, BioLegend, Merck, Abcam, Rockland Immunochemicals, Bio-Rad, Roche, Genscript, Cell Signaling Technology, Santa Cruz Biotechnology, Siemens

Global market segmentation by regions:North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East& Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

The report explains the current state of the market around the world. The report covers the market outline and key components of the globalNeuroscience Antibodies and Assaysmarket which assumes a significant job for clients to settle on the business choice. It focuses on upgrades and development within the global market. By using this report users get a clear perspective on the market conditions, trends, and coming period outlook for various segments. The global market has been segmented on the basis of product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

Access Full Report:https://www.researchstore.biz/report/global-neuroscience-antibodies-and-assays-market-15046

The Analysis Objectives of The Report Are:

Total Chapters In This Market Report Are:

Chapter 1:Overview of globalNeuroscience Antibodies and Assaysmarket

Chapter 2:Global growth trends

Chapter 3:Market share by key players

Chapter 4:Breakdown data by type and application

Chapter 5:North America market status by countries, type, manufacturers and downstream industry

Chapter 6:Europe Market status by countries, type, manufacturers and downstream industry

Chapter 7:Asia Pacific market status by countries, type, manufacturers and downstream industry

Chapter 8:South America market status by countries, type, manufacturers and downstream industry

Chapter 9:the Middle East and Africa market status by countries, type, manufacturers and downstream industry

Chapter 10:Market driving factor analysis

Chapter 11:Market competition status by major manufacturers

Chapter 12:International players profiles

Chapter 13:Market Forecast 2020-2025

Chapter 14:Analysts Viewpoints/Conclusions

Chapter 15:Appendix

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@researchstore.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Researchstore.biz is a fully dedicated global market research agency providing thorough quantitative and qualitative analysis of extensive market research.Our corporate is identified by recognition and enthusiasm for what it offers, which unites its staff across the world.We are desired market researchers proving a reliable source of extensive market analysis on which readers can rely on. Our research team consist of some of the best market researchers, sector and analysis executives in the nation, because of which Researchstore.biz is considered as one of the most vigorous market research enterprises. Researchstore.biz finds perfect solutions according to the requirements of research with considerations of content and methods. Unique and out of the box technologies, techniques and solutions are implemented all through the research reports.

Contact UsMark StoneHead of Business DevelopmentPhone:+1-201-465-4211Email:sales@researchstore.bizWeb:www.researchstore.biz

Go here to see the original:
Global Neuroscience Antibodies and Assays Market 2020 With COVID-19 Impact on Company, Regions, Type and Application, Forecast to 2025 - NJ MMA News

Neuroscience

Chinese Academy of Science Researcher Accused of Academic Plagiarism – Caixin Global

Whats new: Yang Hui, a researcher at the Chinese Academy of Sciences Institute of Neuroscience, has been accused of academic plagiarism for his study published in the journal Cell in April.

Fu Xiangdong, a professor of cellular and molecular medicine at the University of California, San Diego, reportedly accused Yang of plagiarizing a study on Parkinsons disease that his team submitted to the journal Nature in November 2018, according to a letter (link in Chinese) circulating online. Fus study was published last month.

In response to the controversy, the Institute of Neuroscience said Friday in a statement (link in Chinese) that it will investigate the matter and disclose any findings to the public. In his own statement (link in Chinese) Friday, Yang said hes cooperating with the investigation.

Whats the background: Fu, 63, said in the letter that he had presented the unpublished results and design of his study at a briefing that Yang attended at the Institute of Neuroscience in June 2018. Yang dined with Fu afterward and later consulted him about the study, according to the letter.

According to Cells website, it received Yangs study in August 2019, accepted it in March and published it in April.

Quick Takes are condensed versions of China-related stories for fast news you can use. To read the full Caixin article in Chinese, click here.

Contact reporter Timmy Shen (hongmingshen@caixin.com) and editor Michael Bellart (michaelbellart@caixin.com)

Register to read this article for free.

Register

Read the original here:
Chinese Academy of Science Researcher Accused of Academic Plagiarism - Caixin Global

Neuroscience

Trending News Corona impact on Neuroscience Market Drivers And Restrains, Along With Their Current And Expected Impact Till 2025| GE Healthcare,…

The global Neuroscience Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Neuroscience Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Neuroscience Market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Neuroscience Market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Neuroscience Market.

Leading players of the global Neuroscience Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Neuroscience Market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Neuroscience Market. It also provides useful recommendations for new as well as established players of the global Neuroscience Market.

Final Neuroscience Report will add the analysis of the impact of COVID-19 on this Market.

Neuroscience Market competition by top manufacturers/Key player Profiled:GE Healthcare, Siemens Healthineers, Noldus Information Technology, Mightex Bioscience, Thomas RECORDING GmbH, Blackrock Microsystems, Tucker-Davis Technologies, Plexon, Phoenix Technology Group, NeuroNexus, Alpha Omega

Request for Sample Copy of This Report @https://www.reporthive.com/request_sample/2298403

the Global Neuroscience Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Neuroscience market, the market size and growth, as well as the major market participants.

Segmentation by Product:Whole Brain Imaging, Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Stereotaxic Surgeries, Animal Behavior, Others

Segmentation by Application:Hospitals, Diagnostic Laboratories, Research Institutes, Others

Competitive Analysis:

Global Neuroscience Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Neuroscience Market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Scope of the Report:The all-encompassing research weighs up on various aspects including but not limited to important industry definition, product applications, and product types. The pro-active approach towards analysis of investment feasibility, significant return on investment, supply chain management, import and export status, consumption volume and end-use offers more value to the overall statistics on the Neuroscience Market. All factors that help business owners identify the next leg for growth are presented through self-explanatory resources such as charts, tables, and graphic images.

Key Questions Answered:

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

For Customised Template PDF Report:https://www.reporthive.com/request_customization/2298403

Table of Contents

Report Overview:It includes major players of the global Neuroscience Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Neuroscience Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Neuroscience Market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Neuroscience Market by application, it gives a study on the consumption in the global Neuroscience Market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Neuroscience Market are profiled in this section. The analysts have provided information about their recent developments in the global Neuroscience Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Neuroscience Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Neuroscience Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Neuroscience Market.

Key Findings: This section gives a quick look at important findings of the research study.

About Us:Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Contact Us:

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: https://www.reporthive.com

Email: [emailprotected]

Phone: +1 312-604-7084

Follow this link:
Trending News Corona impact on Neuroscience Market Drivers And Restrains, Along With Their Current And Expected Impact Till 2025| GE Healthcare,...

Neuroscience

Far From Home: Oregon The Clarion – Clarion

A quick look at new Bethel arrivals from across the nation and overseas.

By Rachel Blood

This week, the Clarion spoke to incoming freshman Joshua Hahn about his journey from Canada to Oregon and how he discovered a small midwestern campus from Portland. Joshua is a neuroscience major and has been playing piano for twelve years.

Q&A: Joshua Hahn (OR)

Q: Where you were born, where did you grow up, and where do you live now?

A: I was born in Toronto, Canada, but moved straight to Portland, Oregon, and have lived here ever since.

Q: How did you first hear about Bethel?

A: I heard about Bethel through a Bethel alum. The head of the board of Bethel Alumni actually goes to my church, and they recommended the school to me.

Q: What made you choose to attend school so far from home?

A: I visited multiple schools and Bethel just felt like home. I wanted to attend a school farther from home so I could be independent and relatively self-supported.

Q: What do you plan to study at Bethel?

A: Im hoping to major in neuroscience and maybe minor in music.

Q: Do you plan on playing sports or being involved in music or theater at Bethel?

A: I definitely will be involved in music at Bethel. I plan on being in the orchestra or an ensemble as well as the Bethel worship team (like Vespers or something).

Like Loading...

The rest is here:
Far From Home: Oregon The Clarion - Clarion

Neuroscience

Brain Machine Interfaces and Neuromodulation Market Breaking new Grounds and touch new Level in Upcoming Year by Advanced Bionics, Advanced Brain…

Brain Machine Interfaces and Neuromodulation Marketreport focused on the comprehensive analysis of current and future prospects of the Brain Machine Interfaces and Neuromodulation industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors.

This report provides an in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Brain Machine Interfaces and Neuromodulation market has been done in order to calculate the growth rates for each segment and sub-segments.The report also provides the market impact and new opportunities created due to the COVID19 pandemic.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report:

https://www.a2zmarketresearch.com/sample?reportId=266689

Top Key Vendors of this Market are:

Advanced Bionics, Advanced Brain Monitoring, BIOS, Bitbrain, BrainCo, Cochlear Limited, Cognixion, Dreem, Emotiv, Flow Neuroscience, Halo Neuroscience, InteraXon, MED-EL, Neurable, Neuralink, NeuroPace, Neuros Medical, NeuroSky, Nextmind, Paradromics, Synchron, Thync, Versus.

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Brain Machine Interfaces and Neuromodulation market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Brain Machine Interfaces and Neuromodulation markets trajectory between forecast periods.

The report provides insights on the following pointers:

Market Penetration:Comprehensive information on the product portfolios of the top players in the Brain Machine Interfaces and Neuromodulation market.

Product Development/Innovation:Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development:Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments in the Brain Machine Interfaces and Neuromodulation market.

Hurry Up! Get Upto 25% Discount on this Report:

https://www.a2zmarketresearch.com/discount?reportId=266689

Reasons for buying this report:

Table of Contents

Global Brain Machine Interfaces and Neuromodulation Market Research Report 2020 2026

Chapter 1 Brain Machine Interfaces and Neuromodulation Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Brain Machine Interfaces and Neuromodulation Market Forecast

Buy Comprehensive Research Report at:

https://www.a2zmarketresearch.com/buy?reportId=266689

If you have any special requirements, please let us know and we will offer you the report as you want.

Read more:
Brain Machine Interfaces and Neuromodulation Market Breaking new Grounds and touch new Level in Upcoming Year by Advanced Bionics, Advanced Brain...